Alkermes
demonstrated dose dependent increased wakefulness and reduced cataplexy in predictive model mean one way mouse model of narcolepsy serves as a predictive disease model of narcolepsy in humans black conditional ablation of neurons a new mouse model for the study of narcolepsy and system function in collaboration with sri international | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
140 of 144
Similar slides by Alkermes
See diffirences between slides (animation)
Investor Presentation
March 2023
selective agonist showed dose dependent increased wakefulness and reduced cataplexy in preclinical models | Alkermes
Investor Presentation
January 2023
selective agonist showed dose dependent increased wakefulness and reduced cataplexy in preclinical models | Alkermes
Related slides by other companies
Genprex
Investor Presentation
November 2024
reversed drug induced diabetes in toxin induced mouse model | Genprex
Recursion Pharmaceuticals
Investor Day
January 2023
clinical efficacy found in in mice models led to significant progression free survival further confidence preclinical studies confirming insight | Recursion Pharmaceuticals
Arbutus Biopharma
Investor Presentation
August 2023
reduces in mouse model | Arbutus Biopharma
OKYO Pharma
Results
June 2023
validation efficacy in dry eye mouse model | OKYO Pharma
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io